C. Tieken

Small deletions but not methylation underlie CDKN2A/p16 loss of expression in conventional osteosarcoma

A. Cleton-Jansen, P. Hogendoorn, P. A. van der Velden, 2010, Genes, chromosomes & cancer.

Alternatively spliced tissue factor synergizes with the estrogen receptor pathway in promoting breast cancer progression

P. Reitsma, P. Kuppen, H. Versteeg, 2015, Journal of thrombosis and haemostasis : JTH.

The direct oral anticoagulants rivaroxaban and dabigatran do not inhibit orthotopic growth and metastasis of human breast cancer in mice

Sylvia E. Le Dévédec, H. Versteeg, E. Laghmani, 2019, Journal of thrombosis and haemostasis : JTH.

High levels of protein C are determined by PROCR haplotype 3

P. Reitsma, F. Rosendaal, S. Middeldorp, 2011, Journal of thrombosis and haemostasis : JTH.

Alternatively spliced tissue factor promotes breast cancer growth in a β1 integrin-dependent manner

P. Reitsma, P. Kuppen, C. V. D. van de Velde, 2013, Proceedings of the National Academy of Sciences.

Tissue factor associates with survival and regulates tumour progression in osteosarcoma

P. Reitsma, A. Cleton-Jansen, H. Gelderblom, 2016, Thrombosis and Haemostasis.

Title: Tissue factor isoforms in cancer and blood coagulation Issue Date: 2015-04-29 Chapter 7-Alternatively spliced Tissue Factor synergizes with estrogen receptor pathway to stimulate breast cancer progression

C. Tieken, D. Vreeken, B. Kocatürk, 2015 .

Anticoagulants versus cancer.

H. Versteeg, C. Tieken, 2016, Thrombosis research.

Tumor-expressed factor VII is associated with survival and regulates tumor progression in breast cancer

P. Kuppen, E. Stanganello, H. Versteeg, 2023, Blood advances.